Back to Mobile View

cancer

A court ruling Monday stubbed out an FDA attempt to plaster extremely graphic warning labels on cigarette packs. The decision has reignited a debate over which right trumps which: The right of the government to warn Americans about the health risks of smoking, or the First Amendment rights of tobacco companies.
The majority of gold demand these days goes to jewelry and investors, but the precious metal is good for more than looking pretty and providing a hard asset: Industrial and technological uses for gold are growing.
Last week, Dallas County in Texas joined the growing ranks of employers that charge employees who smoke a higher monthly health insurance premium than employees who don't. It's an idea that's gaining momentum across the country -- but will it work to reduce smoking, or just to penalize the nicotine-addicted?
Tobacco giant Philip Morris International has just bought the rights to a new technology for delivering nicotine in a aerosol spray. The upside: Nicotine addicts get their fix without all the toxins associated with smoking. The downside: It'll be at least three years before it hits the market.
As the crisis at Japan's Fukushima Daiichi nuclear plant continues, some worry that radiation from the damaged reactors will reach U.S. shores. Dr. Edward Maher, president of the Health Physics Society, and an environmental science expert at Harvard, explains why we should breathe easy.
Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis. Here's why the move could prove an ill-needed distraction for the electronics giant.
The Center for Science in the Public Interest today called on the U.S. Food and Drug Administration to ban the use of certain caramel coloring in foods and sodas including Coca-Cola and Pepsi products, pointing to research that showed the additive caused cancer in lab mice and rats. "If consumers...
Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren't drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.
Pfizer's cancer drug Sutent and Novartis's drug Afinitor have both been found to be effective against the rare form of pancreatic cancer that Apple CEO Steve Jobs was diagnosed with in 2004, according to two studies published in the New England Journal of Medicine.
To get potentially lifesaving drugs to patients faster, the U.S. Food and Drug Administration is allowed to approve some drugs -- those that address unmet medical needs -- based on fewer trials than usual. But it turns out that many of the pharmaceutical companies fail to conduct follow-up trials to prove the drugs work.

Market Movers

SymbolLastChange / %Volume

Most Actives

BAC
Bank of America Corp
8.07-0.11
-1.34%
254.23M
ALU
Alcatel-Lucent (ADR)
2.19+0.25
+12.89%
122.18M
GE
General Electric Company
18.88-0.26
-1.33%
109.55M
F
Ford
12.44-0.25
-1.97%
52.49M

% Gainers

CIE
Cobalt International Energy
31.68 +7.78
+32.55%
18.42M
LNKD
LinkedIn Corp.
89.96 +13.57
+17.76%
13.27M
ALU
Alcatel-Lucent (ADR)
2.19 +0.25
+12.89%
122.18M
WNS
WNS (Holdings) Limited (ADR)
10.50 +1.10
+11.70%
3.07M

% Losers

NBG-A
National Bank of Greece SA (ADR)
5.72-1.03
-15.26%
188,505
OSG
Overseas Shipholding Group, Inc.
10.18-1.65
-13.95%
1.88M
AB
AllianceBernstein Holding LP
14.35-2.16
-13.08%
1.30M
OC-B
Owens Corning (Warrant) 'B'
2.31-0.34
-12.83%
26,436
Newswire

Follow Us

Headlines From DailyFinance Partners

CNN Money
CNBC
Smart Money
Consumer Reports
Huffington Post
AOL Energy
AOL Jobs
Business News Personal Finance Investing Our Partners

DailyFinance Sitemap | Terms of Service | Privacy Policy | Trademarks | HELP | Advertise With Us

© Copyright 2012 AOL Inc. All Rights Reserved